Sr. Manager - Brand Management, Diagnosis and Innovations at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree in life science or business
Master’s degree in business-related field (plus)
Experience in innovative medicine(s) (must)
Experience in diagnostics, vaccines, and/or neuroscience (plus)
Experience in cross-functional leadership & Project Management ownership
Experience working closely with global/IBU teams (plus)
Very good command of English (written/oral)
Very good command of Chinese (written/oral)
Team player with self-awareness
Learning agility, analytical, critical and strategic thinking
Influencing skills and ability to connect with senior leaders and field teams
Self-starter, driven with sense of ownership
Highest standards of ethics

Responsibilities

Work with Marketing (Brand, Diagnosis, Consumer, Omni-Channel Engagement, Market Research, etc.), Corporate Affairs, Medical Affairs to build national and regional Operation Plan to improve ecosystem readiness for innovation
Work with Diagnosis related internal and external counterparts to drive execution to improve testing uptake
Support AD portfolio’s Innovation Readiness and future indication Launch Readiness coordination
Design and implement China AD Innovation Readiness Strategy and new launch readiness for future indications
Work with cross-functional teams engaging with local government and scientific communities to support the advancement of the local ecosystem and B2G Strategy

Skills

Brand Management

Marketing Strategy

Market Research

Omni-Channel Engagement

Cross-functional Collaboration

B2G Strategy

Launch Readiness

Diagnostics

Innovation Strategy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free